New York, NY—July 24, 2018
South Korea’s leading orthopedic specialty hospital network, Bumin Hospital Group (BHG), has extended its relationship with New York-based HSS, a world leader in musculoskeletal health. Since engaging with HSS in 2014, BHG has achieved operating efficiencies through transfer of HSS best practices and partnering on education and research.
HSS includes Hospital for Special Surgery, the world’s leading academic medical center focused on musculoskeletal health, ranked #1 for Orthopedics for the eighth consecutive year by USNews & World Report 'Best Hospitals' (2017-18). HSS is also a world leader in rheumatology and research, innovation and education related to musculoskeletal health.
"HSS is advancing state of the art musculoskeletal care globally through research, innovation, and a variety of collaborations with quality-focused organizations such as Bumin Hospital Group," said Louis A. Shapiro, president and chief executive officer of HSS. "We have a substantial responsibility and opportunity to distribute knowledge and capabilities that help consumers and providers to realize their potential."
In the first phase of their collaboration in 2014, an HSS expert team worked with BHG to develop strategies for advancing surgical, non-surgical, and rehabilitation outcomes, and improve operational efficiencies. HSS clinical and educational teams helped guide transformations at two BHG units -- Busan Bumin Hospital and Seoul Bumin Hospital.
The focus of the two-year engagement extension (2018-20) will be on strengthening the Quality Improvement and Infection Control programs at Seoul Bumin Hospital and Haeundae Bumin Hospital. Both facilities will work towards achieving by 2020 the designation of HSS Center of Excellence, a certification of advanced care delivery accompanied by continuing development support from and membership in the HSS Global Orthopedic Alliance Network.
"We are pleased to have the opportunity to work with BHG and share the depth of our experience in delivering world class orthopedic and rehabilitative care," said HSS Vice Chairman of Education and Academic Affairs Mathias P. Bostrom, M.D.. "Bumin Hospital shares many values with HSS, including a commitment to promoting musculoskeletal health in the global society by providing the best possible care to patients."
About Bumin Hospital Group
Bumin Hospital Group (BHG) operates four hospitals in South Korea with a total bed size of more than 1,200 including Bumin Hospital, a leading specialty hospital in musculoskeletal medicine in South Korea. To raise its clinical standards, Bumin has established clinical pathways for major surgeries and implemented a customer-oriented treatment system.
About HSS | Hospital for Special Surgery
HSS is the world’s leading academic medical center focused on musculoskeletal health. At its core is Hospital for Special Surgery, nationally ranked No. 1 in orthopedics (for the ninth consecutive year) and No. 3 in rheumatology by U.S.News & World Report (2018-2019). Founded in 1863, the Hospital has one of the lowest infection rates in the country and was the first in New York State to receive Magnet Recognition for Excellence in Nursing Service from the American Nurses Credentialing Center four consecutive times. The global standard total knee replacement was developed at HSS in 1969. An affiliate of Weill Cornell Medical College, HSS has a main campus in New York City and facilities in New Jersey, Connecticut and in the Long Island and Westchester County regions of New York State. In 2017 HSS provided care to 135,000 patients and performed more than 32,000 surgical procedures. People from all 50 U.S. states and 80 countries travelled to receive care at HSS. In addition to patient care, HSS leads the field in research, innovation and education. The HSS Research Institute comprises 20 laboratories and 300 staff members focused on leading the advancement of musculoskeletal health through prevention of degeneration, tissue repair and tissue regeneration. The HSS Global Innovation Institute was formed in 2016 to realize the potential of new drugs, therapeutics and devices. The culture of innovation is accelerating at HSS as 130 new idea submissions were made to the Global Innovation Institute in 2017 (almost 3x the submissions in 2015). The HSS Education Institute is the world’s leading provider of education on the topic of musculoskeletal health, with its online learning platform offering more than 600 courses to more than 21,000 medical professional members worldwide. Through HSS Global Ventures, the institution is collaborating with medical centers and other organizations to advance the quality and value of musculoskeletal care and to make world-class HSS care more widely accessible nationally and internationally.